The recent presentation by Tonix Pharmaceuticals Holding Corp. at the 2025 Annual European Congress of Rheumatology (EULAR) in Barcelona has brought hope to millions suffering from fibromyalgia. The company showcased positive Phase 3 data for TNX-102 SL, a sublingual formulation of cyclobenzaprine, which demonstrated statistically significant and sustained pain reduction over 14 weeks in patients […]
Lantern Pharma Inc. (NASDAQ: LTRN) has achieved a significant milestone in the treatment of advanced non-small cell lung cancer (NSCLC), with a patient in its Phase 2 HARMONIC(TM) trial achieving a durable complete response. This development is particularly noteworthy as the patient, a 70-year-old never-smoker, had previously failed three lines of therapy, including treatments with […]
In an era where the biotech industry faces significant challenges, including regulatory hurdles and the financial instability associated with ‘one-shot cures,’ Jupiter Neurosciences Inc. stands out with its innovative approach. The company is not only advancing in the development of treatments for central nervous system (CNS) disorders such as Alzheimer’s and Parkinson’s but is also […]
SolarBank Corporation, a leader in renewable and clean energy project development, has announced significant progress on its 2.4 MW DC Sydney project in Nova Scotia. This initiative not only underscores the company’s expansion in the Canadian community solar market but also aligns with Nova Scotia’s ambitious target of achieving 80% renewable energy by 2030. The […]
Walker Lane Resources Ltd. (TSXV: WLR), under the leadership of President and CEO Kevin Brewer, has recently detailed its ambitious exploration strategy targeting high-grade gold and silver projects across Nevada and British Columbia. This strategic direction was shared in a webinar hosted by the Investing News Network (INN), shedding light on the company’s plans to […]
The advent of HeartBeam Inc.’s cable-free system marks a significant milestone in cardiac care technology. This innovative system synthesizes a 12-lead electrocardiogram (ECG) from 3D, non-coplanar electrical signals captured in real time, a first in the medical technology field. The implications of this development are profound, offering patients the ability to record an ECG in […]
BiomX Inc., a biotech company with a market cap of approximately $10 million, has made strides in the fight against antibiotic-resistant infections, a growing global health crisis. Their recent Phase 2 clinical trial results for treating diabetic foot osteomyelitis and cystic fibrosis with bacteriophage therapy have shown promising outcomes, potentially positioning the company as a […]
As the nation prepares to celebrate Independence Day with fireworks and parades, a new book titled ‘Fractured to Freedom’ by Al Perry offers a different perspective on freedom. Launching on July 4, the book shifts the focus from collective celebrations to personal liberation, suggesting that true independence begins with healing from within. Perry’s work is […]
In the current healthcare payment environment, where providers face increasing challenges from shrinking reimbursements and payer resistance, CollectionPro Services LLC has emerged as a beacon of hope. The company’s innovative approach combines legal expertise with a no-risk financial model, enabling healthcare providers to recover out-of-network (OON) payments effectively. This model is particularly significant in light […]
The recent VALID-ECG study conducted by HeartBeam Inc. (NASDAQ: BEAT) has showcased the remarkable diagnostic accuracy of its synthesized 12-lead ECG device, achieving a 93.4% agreement with traditional ECG methods for arrhythmia assessment. This pivotal study, presented by Dr. Thomas Deering of the Piedmont Heart Institute at the Heart Rhythm Society’s annual meeting in San […]